SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-013436
Filing Date
2024-04-26
Accepted
2024-04-26 16:39:49
Documents
17
Period of Report
2024-04-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20240423_8k.htm   iXBRL 8-K 31438
2 EXHIBIT 3.1 ex_659342.htm EX-3.1 8349
3 EXHIBIT 99.1 ex_659343.htm EX-99.1 12927
8 ex_659343img001.jpg GRAPHIC 10722
  Complete submission text file 0001437749-24-013436.txt   212511

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atxi-20240425.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20240425_def.xml EX-101.DEF 11804
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20240425_lab.xml EX-101.LAB 15848
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20240425_pre.xml EX-101.PRE 12019
20 EXTRACTED XBRL INSTANCE DOCUMENT atxi20240423_8k_htm.xml XML 2954
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 24884581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)